icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
JeQRngg8RLgLC5hq
Listen
